Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib
Amir Noeparast(Vrije Universiteit Brussel), Jacques De Grève(Vrije Universiteit Brussel)
Cited by 100
Related Papers
miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells
|PLoS ONE|2013|267
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
|BMC Medicine|2012|131
Synergistic Effect of Afatinib with Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib
|PLoS ONE|2013|51
Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells
|Biological Procedures Online|2010|46